EBANG INTERNATIONAL HLDGS-A (EBON)

KYG3R33A2053 - Common Stock

7.85  +0.05 (+0.64%)

After market: 7.75 -0.1 (-1.27%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to EBON. EBON was compared to 32 industry peers in the Technology Hardware, Storage & Peripherals industry. While EBON has a great health rating, there are worries on its profitability. EBON does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

EBON had negative earnings in the past year.
EBON had negative earnings in 4 of the past 5 years.
EBON had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

EBON has a Return On Assets of -12.77%. This is in the lower half of the industry: EBON underperforms 71.88% of its industry peers.
With a Return On Equity value of -13.46%, EBON perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
ROA -12.77%
ROE -13.46%
ROIC N/A
ROA(3y)-10.97%
ROA(5y)-18.49%
ROE(3y)-14.11%
ROE(5y)-59.57%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

EBON has a Gross Margin of 19.01%. This is in the lower half of the industry: EBON underperforms 75.00% of its industry peers.
EBON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

EBON does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EBON has more shares outstanding
There is no outstanding debt for EBON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

An Altman-Z score of 2.11 indicates that EBON is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.11, EBON is in line with its industry, outperforming 59.38% of the companies in the same industry.
There is no outstanding debt for EBON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.11
ROIC/WACCN/A
WACC9.8%

2.3 Liquidity

EBON has a Current Ratio of 27.87. This indicates that EBON is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 27.87, EBON belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
EBON has a Quick Ratio of 27.82. This indicates that EBON is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 27.82, EBON belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 27.87
Quick Ratio 27.82

0

3. Growth

3.1 Past

The earnings per share for EBON have decreased strongly by -1044.00% in the last year.
EBON shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -37.28%.
The Revenue for EBON have been decreasing by -33.35% on average. This is quite bad
EPS 1Y (TTM)-1044%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q22.36%
Revenue 1Y (TTM)-37.28%
Revenue growth 3Y-33.35%
Revenue growth 5YN/A
Revenue growth Q2Q-83.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

EBON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for EBON!.
Industry RankSector Rank
Dividend Yield N/A

EBANG INTERNATIONAL HLDGS-A

NASDAQ:EBON (4/26/2024, 7:00:02 PM)

After market: 7.75 -0.1 (-1.27%)

7.85

+0.05 (+0.64%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap49.30M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.77%
ROE -13.46%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 19.01%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 27.87
Quick Ratio 27.82
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1044%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-37.28%
Revenue growth 3Y-33.35%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y